Compare EXAS & HUM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EXAS | HUM |
|---|---|---|
| Founded | 1995 | 1961 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.7B | 22.5B |
| IPO Year | 2000 | 2002 |
| Metric | EXAS | HUM |
|---|---|---|
| Price | $103.31 | $165.45 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 17 | 20 |
| Target Price | $86.62 | ★ $241.60 |
| AVG Volume (30 Days) | ★ 1.8M | 1.8M |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.07% |
| EPS Growth | ★ 80.32 | N/A |
| EPS | N/A | ★ 9.84 |
| Revenue | $4,144,000.00 | ★ $129,664,000,000.00 |
| Revenue This Year | $15.37 | $24.46 |
| Revenue Next Year | $12.41 | $6.58 |
| P/E Ratio | ★ N/A | $17.36 |
| Revenue Growth | N/A | ★ 10.11 |
| 52 Week Low | $38.88 | $169.61 |
| 52 Week High | $104.02 | $315.35 |
| Indicator | EXAS | HUM |
|---|---|---|
| Relative Strength Index (RSI) | 54.45 | 29.31 |
| Support Level | $102.95 | N/A |
| Resistance Level | $103.77 | $192.01 |
| Average True Range (ATR) | 0.31 | 6.02 |
| MACD | -0.09 | 0.80 |
| Stochastic Oscillator | 33.18 | 1.96 |
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.